ArticleFrontiers in surgery2026
Clinical outcomes of flap reconstruction following lower extremity soft tissue sarcoma resection: a single-center retrospective experience.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Soft tissue sarcomas (STSs) represent a diverse category of tumors with a propensity for the lower limbs. Wide surgical resection is the primary therapeutic approach, often requiring immediate flap reconstruction with or without perioperative adjuvant therapy. This study aims to share our clinical experience and assess the efficacy of customized flap reconstruction designed according to the precise defect area after lower extremity STS resection. Methods: This retrospective analysis reviewed 15 cases of lower extremity STS with a median follow-up of 28.5 months (range: 8-58 months), where patients underwent flap reconstruction with or without adjuvant therapy at our institution. Owing to the small cohort size, analyses were primarily descriptive. Continuous variables were summarized as the median, interquartile range, and range, whereas categorical variables were reported as frequencies and percentages. Exact 95% confidence intervals were calculated for selected proportions. Results: The cohort comprised 7 male (46.7%) and 8 female (53.3%) patients, with a median age of 65.0 years (IQR, 52.0-76.8 years; range, 31-86 years). All patients achieved microscopic negative margins (R0 resection), and 10 (66.7%) received adjuvant therapy. The median flap surface area was 120 cm² (IQR, 80-171 cm Conclusion: In this single-center retrospective series, flap-based reconstruction was a feasible limb-salvage strategy after lower extremity STS resection, providing reliable coverage for complex defects. Although postoperative complications occurred in some patients, flap reconstruction remained an important component of multidisciplinary limb-preservation treatment, particularly when combined with careful perioperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.